Cargando…
Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study
Next generation sequencing analysis is crucial for therapeutic decision in various solid tumor contexts. The sequencing method must remain accurate and robust throughout the instrument lifespan allowing the biological validation of patients’ results. This study aims to evaluate the long-term sequenc...
Autores principales: | Bamba-Funck, Jessica, Fabre, Emmanuelle E., Kambouchner, Marianne, Schischmanoff, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001101/ https://www.ncbi.nlm.nih.gov/pubmed/36900081 http://dx.doi.org/10.3390/diagnostics13050937 |
Ejemplares similares
-
Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus
por: Vestergaard, Lau K., et al.
Publicado: (2021) -
Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer
por: Park, Joonhong, et al.
Publicado: (2020) -
Validation of the Oncomine(™) focus panel for next-generation sequencing of clinical tumour samples
por: Williams, Hannah L., et al.
Publicado: (2018) -
Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations
por: Cho, Yong Gon, et al.
Publicado: (2023) -
Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2022)